Association of polymorphisms in the human interferon-γ and interleukin-10 gene with acute and chronic kidney transplant outcome -: The cytokine effect on transplantation

被引:117
作者
Asderakis, A
Sankaran, D
Dyer, P
Johnson, RWG
Pravica, V
Sinnott, PJ
Roberts, I
Hutchinson, IV
机构
[1] Manchester Royal Infirm, Renal Transplant Unit, Manchester M13 9WL, Lancs, England
[2] Manchester Royal Infirm, Transplantat Lab, Manchester M13 9WL, Lancs, England
[3] Univ Manchester, Sch Biol Sci, Immunol Grp, Manchester M13 9WL, Lancs, England
[4] Royal London Hosp, Tissue Typing Lab, London E1 1BB, England
关键词
D O I
10.1097/00007890-200103150-00018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background, Our group has previously described five different size alleles of an interferon (IFN)-gamma microsatellite, Analyzing this polymorphism, this study correlated high IFN-gamma production with a 12 CA repeat allele (allele 2), Further, our group has described interleukin (IL)-10 polymorphism defining in vitro high and low IL-IO producer status, Methods. Samples from 88 of 115 consecutive cadaveric renal transplants were used to define polymorphism of both IFN-gamma and IL-10, Patients were separated into high and low genotypes based on the previously reported association between certain genotypes and in vitro production. Graft survival, acute rejection, and serum creatinine at B years were analyzed for comparison between groups. Results. The genotype associated with high IFN-gamma production was found in 70 patients. The incidence of acute rejection was 54.3% in the high IFN-gamma genotype group, compared with 44.4% in the low IFN-gamma group. Requirement for antithymocyte globulin therapy was greater in the high IFN-gamma group (odds ratio [OR]=2.5), Among HLA-DR-mismatched patients, IFN-gamma genotype was more strongly associated with rejection (OR=2.86), In the cyclosporine monotherapy subgroup, patients with high IFN-gamma genotype had a 61% incidence of rejection compared with only 20% in the low IFN-gamma genotype patients (OR=3.06), Graft survival was similar between the two groups. When the analysis was controlled for the presence of delayed graft function, 40.5% of the high IFN-gamma genotype patients had serum creatinine levels above 200 mu mol/L compared with only 14.3% of the low IFN-gamma genotype recipients at 5 years after transplantation (P=0.05), The high IL-10 genotype was shown to be associated with better graft function at 5 years (75 vs. 50%, P=0.09), Conclusion. In this study we have shown that high producer genotype for IFN-gamma may have an influence on acute rejection of kidney transplants, particularly in patients on cyclosporine monotherapy, It is also associated with worse long-term graft function. On the contrary high IL-10 production may have a long-term protective effect.
引用
收藏
页码:674 / 678
页数:5
相关论文
共 22 条
[1]  
ASDERAKIS A, 1997, IMMUNOLOGY S1, V92, P15
[2]   Use of mycophenolate mofetil for prevention of acute rejection in renal transplantation [J].
Carl, S ;
Wiesel, M ;
Staehler, G .
UROLOGE-AUSGABE A, 1998, 37 (03) :282-286
[3]  
CHEN WF, 1991, J IMMUNOL, V147, P528
[4]  
DOHERTY TM, 1995, CURR OPIN IMMUNOL, V7, P400
[5]   INTERLEUKIN-10, A NOVEL B-CELL STIMULATORY FACTOR - UNRESPONSIVENESS OF X-CHROMOSOME LINKED IMMUNODEFICIENCY-B CELLS [J].
GO, NF ;
CASTLE, BE ;
BARRETT, R ;
KASTELEIN, R ;
DANG, W ;
MOSMANN, TR ;
MOORE, KW ;
HOWARD, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1625-1631
[6]   Mycophenolate mofetil in renal allograft recipients - A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection [J].
Halloran, P ;
Mathew, T ;
Tomlanovich, S ;
Groth, C ;
Hooftman, L ;
Barker, C .
TRANSPLANTATION, 1997, 63 (01) :39-47
[7]  
HALLORAN PF, 1993, TRANSPL SCI JUL, P92
[8]  
MOSMANN TR, 1991, IMMUNOL TODAY, V12, P49
[9]   CYTOKINES AND THE TH1/TH2 PARADIGM IN TRANSPLANTATION [J].
NICKERSON, P ;
STEURER, W ;
STEIGER, J ;
ZHENG, XX ;
STEELE, AW ;
STROM, TB .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (05) :757-764
[10]   Evaluation of immunosuppressive induction regimens in renal transplantation [J].
Opelz, G .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) :4029-4030